We provide you with 20 years of free, institutional-grade data for BCYC stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BCYC. Explore the full financial landscape of BCYC stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Sands Stephen H. | Grant, award...etc | 12,000 | 2024-02-21 | ||
| Arroyo Santiago | Grant, award...etc | 21,660 | 2024-02-08 | ||
| Gutierrez-Ramos Jose-Carlos | Grant, award...etc | 6,000 | 2024-01-04 | ||
| Jordan Veronica GH | Grant, award...etc | 6,000 | 2024-01-04 | ||
| Kender Richard N | Grant, award...etc | 6,000 | 2024-01-04 | ||
| Winter Gregory Paul | Grant, award...etc | 6,000 | 2024-01-04 | ||
| Arroyo Santiago | Grant, award...etc | 17,340 | 2024-01-04 | ||
| Young Alethia | Grant, award...etc | 12,000 | 2024-01-04 | ||
| Crockett Nigel | Sale | -2,643 | $17.5 | $46,253 | 2024-01-04 |
| Crockett Nigel | Grant, award...etc | 22,000 | 2024-01-04 | ||
| Milnes Alistair | Sale | -2,643 | $17.5 | $46,253 | 2024-01-04 |
| Milnes Alistair | Grant, award...etc | 39,000 | 2024-01-04 | ||
| Skynner Michael | Sale | -2,643 | $17.5 | $46,253 | 2024-01-04 |
| Skynner Michael | Grant, award...etc | 28,000 | 2024-01-04 | ||
| Lee Kevin | Sale | -8,703 | $17.5 | $152,303 | 2024-01-04 |
| Lee Kevin | Grant, award...etc | 77,000 | 2024-01-04 | ||
| Bourque Janice | Grant, award...etc | 6,000 | 2024-01-04 | ||
| Keen Nicholas | Sale | -2,640 | $17.5 | $46,200 | 2024-01-04 |
| Keen Nicholas | Grant, award...etc | 28,000 | 2024-01-04 | ||
| Legault Pierre | Grant, award...etc | 12,000 | 2024-01-04 | ||
| Thompson Travis Alvin | Sale | -604 | $17.5 | $10,570 | 2024-01-04 |
| Thompson Travis Alvin | Grant, award...etc | 16,000 | 2024-01-04 | ||
| Keen Nicholas | Sale | -272 | $20 | $5,440 | 2023-10-05 |
| Crockett Nigel | Sale | -442 | $20 | $8,840 | 2023-10-05 |
| Milnes Alistair | Sale | -442 | $20 | $8,840 | 2023-10-05 |
| Lee Kevin | Sale | -1,470 | $20 | $29,400 | 2023-10-05 |
| Skynner Michael | Sale | -442 | $20 | $8,840 | 2023-10-05 |
| Thompson Travis Alvin | Sale | -54 | $20 | $1,080 | 2023-10-05 |
| Skynner Michael | Sale | -451 | $25.1 | $11,320 | 2023-07-06 |
| Thompson Travis Alvin | Sale | -61 | $25.1 | $1,531 | 2023-07-06 |
| Milnes Alistair | Sale | -451 | $25.1 | $11,320 | 2023-07-06 |
| Lee Kevin | Sale | -1,498 | $25.1 | $37,600 | 2023-07-06 |
| Keen Nicholas | Sale | -336 | $25.1 | $8,434 | 2023-07-06 |
| Crockett Nigel | Sale | -451 | $25.1 | $11,320 | 2023-07-06 |
| Thompson Travis Alvin | Initial | 2023-07-03 | |||
| Keen Nicholas | Sale | -319 | $21.11 | $6,734 | 2023-04-05 |
| Skynner Michael | Sale | -447 | $21.11 | $9,436 | 2023-04-05 |
| Milnes Alistair | Sale | -447 | $21.11 | $9,436 | 2023-04-05 |
| Crockett Nigel | Sale | -447 | $21.11 | $9,436 | 2023-04-05 |
| Kalowski Lee | Sale | -376 | $21.11 | $7,937 | 2023-04-05 |
| Lee Kevin | Sale | -1,486 | $21.11 | $31,369 | 2023-04-05 |
| Legault Pierre | Grant, award...etc | 11,500 | 2023-01-05 | ||
| Lee Kevin | Sale | -6,000 | $29.06 | $174,360 | 2023-01-05 |
| Lee Kevin | Grant, award...etc | 57,500 | 2023-01-05 | ||
| Gutierrez-Ramos Jose-Carlos | Grant, award...etc | 5,750 | 2023-01-05 | ||
| Winter Gregory Paul | Grant, award...etc | 5,750 | 2023-01-05 | ||
| Jordan Veronica GH | Grant, award...etc | 5,750 | 2023-01-05 | ||
| Crockett Nigel | Sale | -1,801 | $29.06 | $52,337 | 2023-01-05 |
| Crockett Nigel | Grant, award...etc | 17,500 | 2023-01-05 | ||
| Milnes Alistair | Sale | -1,801 | $29.06 | $52,337 | 2023-01-05 |
| Milnes Alistair | Grant, award...etc | 17,500 | 2023-01-05 | ||
| Smethurst Dominic | Sale | -1,801 | $29.06 | $52,337 | 2023-01-05 |
| Smethurst Dominic | Grant, award...etc | 17,500 | 2023-01-05 | ||
| Keen Nicholas | Sale | -1,817 | $29.06 | $52,802 | 2023-01-05 |
| Keen Nicholas | Grant, award...etc | 17,500 | 2023-01-05 | ||
| Skynner Michael | Sale | -1,801 | $29.06 | $52,337 | 2023-01-05 |
| Skynner Michael | Grant, award...etc | 17,500 | 2023-01-05 | ||
| Kalowski Lee | Sale | -1,815 | $29.06 | $52,744 | 2023-01-05 |
| Kalowski Lee | Grant, award...etc | 17,500 | 2023-01-05 | ||
| Bourque Janice | Grant, award...etc | 5,750 | 2023-01-05 | ||
| Kender Richard N | Grant, award...etc | 5,750 | 2023-01-05 | ||
| Milnes Alistair | Derivatives Exercise | 5,155 | 2022-03-29 | ||
| Bourque Janice | Grant, award...etc | 5,000 | 2022-01-05 | ||
| Crockett Nigel | Grant, award...etc | 15,000 | 2022-01-05 | ||
| Milnes Alistair | Grant, award...etc | 15,000 | 2022-01-05 | ||
| Jordan Veronica GH | Grant, award...etc | 5,000 | 2022-01-05 | ||
| Winter Gregory Paul | Grant, award...etc | 5,000 | 2022-01-05 | ||
| Smethurst Dominic | Grant, award...etc | 15,000 | 2022-01-05 | ||
| Kender Richard N | Grant, award...etc | 5,000 | 2022-01-05 | ||
| Skynner Michael | Grant, award...etc | 15,000 | 2022-01-05 | ||
| Lee Kevin | Grant, award...etc | 50,000 | 2022-01-05 | ||
| Legault Pierre | Grant, award...etc | 10,000 | 2022-01-05 | ||
| Kalowski Lee | Grant, award...etc | 15,000 | 2022-01-05 | ||
| Keen Nicholas | Grant, award...etc | 15,000 | 2022-01-05 | ||
| Gutierrez-Ramos Jose-Carlos | Grant, award...etc | 5,000 | 2022-01-05 | ||
| Keen Nicholas | Derivatives Exercise | 15,477 | 2021-12-22 | ||
| Legault Pierre | Sale | -150,000 | $57.02 | $8,553,000 | 2021-12-22 |
| Legault Pierre | Derivatives Exercise | 150,000 | 2021-12-22 | ||
| Lee Kevin | Sale | -5,000 | $60 | $300,000 | 2021-10-18 |
| Lee Kevin | Sale | -5,000 | $53.77 | $268,850 | 2021-10-13 |
| Keen Nicholas | Sale | -3,366 | $45 | $151,470 | 2021-10-05 |
| Smethurst Dominic | Derivatives Exercise | 6,000 | 2021-09-27 | ||
| Keen Nicholas | Sale | -4,955 | $45 | $222,975 | 2021-09-17 |
| Lee Kevin | Sale | -32,085 | $36.38 | $1,167,252 | 2021-09-03 |
| Lee Kevin | Derivatives Exercise | 22,890 | 2021-09-03 | ||
| Kalowski Lee | Sale | -10,000 | $40 | $400,000 | 2021-09-03 |
| Kalowski Lee | Derivatives Exercise | 10,000 | 2021-09-03 | ||
| Keen Nicholas | Sale | -10,000 | $40 | $400,000 | 2021-09-03 |
| Lee Kevin | Sale | -13,033 | $36.02 | $469,449 | 2021-08-31 |
| Lee Kevin | Derivatives Exercise | 12,228 | 2021-08-31 | ||
| Kalowski Lee | Sale | -8,500 | $35.04 | $297,840 | 2021-08-27 |
| Kalowski Lee | Derivatives Exercise | 8,500 | 2021-08-27 | ||
| Kalowski Lee | Sale | -7,500 | $33.02 | $247,650 | 2021-08-25 |
| Kalowski Lee | Derivatives Exercise | 7,500 | 2021-08-25 | ||
| Kalowski Lee | Sale | -12,500 | $31.24 | $390,500 | 2021-07-30 |
| Kalowski Lee | Derivatives Exercise | 12,500 | 2021-07-30 | ||
| Lee Kevin | Sale | -4,882 | $36.02 | $175,850 | 2021-07-27 |
| Lee Kevin | Derivatives Exercise | 4,882 | 2021-07-27 | ||
| BINGHAM KATE | Sale | -929 | $33.5 | $31,122 | 2021-07-20 |
| BINGHAM KATE | Sale | -43,966 | $33.5 | $1,472,861 | 2021-07-20 |
| Keen Nicholas | Sale | -10,000 | $35 | $350,000 | 2021-07-16 |
| Lee Kevin | Sale | -22,579 | $34.28 | $774,008 | 2021-07-16 |
| Lee Kevin | Derivatives Exercise | 22,579 | 2021-07-16 | ||
| BINGHAM KATE | Sale | -929 | $33.5 | $31,122 | 2021-07-15 |
| BINGHAM KATE | Sale | -43,966 | $33.5 | $1,472,861 | 2021-07-15 |
| Crockett Nigel | Sale | -79,729 | $32.03 | $2,553,720 | 2021-07-14 |
| Crockett Nigel | Derivatives Exercise | 79,729 | 2021-07-14 | ||
| Lee Kevin | Sale | -55,362 | $32.04 | $1,773,798 | 2021-07-14 |
| Lee Kevin | Derivatives Exercise | 45,713 | 2021-07-14 | ||
| Crockett Nigel | Sale | -271 | $32 | $8,672 | 2021-07-08 |
| Crockett Nigel | Derivatives Exercise | 271 | 2021-07-08 | ||
| Lee Kevin | Sale | -7,320 | $32.14 | $235,265 | 2021-05-10 |
| Lee Kevin | Derivatives Exercise | 7,320 | 2021-05-10 |
The information provided in this report about BCYC stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Bicycle Therapeutics plc(NASDAQ:BCYC) 
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express...
Website: http://bicycletherapeutics.com
Founded: 2009
IPO Price: $14 (May 23, 2019)
Full Time Employees: 81
CEO: Kevin Lee
Sector: Healthcare
Industry: Biotechnology